Education
About Us
Working with TipRanks
Follow Us
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 165.00K |
| Gross Profit | $ 0.00 | $ 0.00 | $ -1.12M | $ -73.00K | $ 165.00K |
| Operating Income | $ -13.46M | $ -14.01M | $ -169.82M | $ -71.31M | $ -26.70M |
| EBITDA | $ -14.01M | $ -15.25M | $ -169.84M | $ -69.71M | $ -26.68M |
| Net Income | $ -14.70M | $ -15.48M | $ -171.96M | $ -68.38M | $ -21.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.17M | $ 3.06M | $ 248.12M | $ 356.32M | $ 126.08M |
| Total Assets | $ 3.33M | $ 3.90M | $ 286.59M | $ 370.82M | $ 139.42M |
| Total Debt | $ 0.00 | $ 3.25M | $ 30.07M | $ 8.69M | $ 11.76M |
| Net Debt | $ -3.17M | $ 194.00K | $ -171.59M | $ -113.97M | $ -49.33M |
| Total Liabilities | $ 48.35M | $ 34.17M | $ 61.33M | $ 17.76M | $ 190.93M |
| Stockholders' Equity | $ -45.02M | $ -30.27M | $ 225.27M | $ 353.06M | $ -51.50M |
| Cash Flow | |||||
| Free Cash Flow | $ -14.13M | $ -9.78M | $ -106.34M | $ -61.05M | $ -20.49M |
| Operating Cash Flow | $ -14.13M | $ -9.78M | $ -106.32M | $ -60.81M | $ -20.16M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 185.98M | $ -169.50M | $ -64.64M |
| Financing Cash Flow | $ 14.24M | $ 12.78M | $ 232.00K | $ 291.98M | $ 120.92M |